Skip to main content
logo
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
40.36
-0.66 (-1.61%)
Aug 13, 2026, 5:29 PM CET

Hansa Biopharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-656.57-534.11-807.24
Depreciation & Amortization
43.4138.7628.06
Other Adjustments
177.66-16.21168.33
Change in Receivables
-9.43-35.16-66.94
Changes in Accounts Payable
15.7316.44-49.35
Changes in Other Operating Activities
-129.57-56.5-11.77
Operating Cash Flow
-579.63-549.17-674.88
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
---0.12
Investing Cash Flow
15--0.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Long-Term Debt Issued
271.11--
Long-Term Debt Repaid
-136.87--
Net Long-Term Debt Issued (Repaid)
134.24--
Issuance of Common Stock
647.53865.6354.31
Net Common Stock Issued (Repurchased)
647.53865.6354.31
Other Financing Activities
-8.99-17.64-7.5
Financing Cash Flow
763.25847.96346.81

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
-0.23-2.991.42
Net Cash Flow
198.63298.79-328.2

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-579.63-549.17-675
Free Cash Flow Growth
---
FCF Margin
-305.94%-247.08%-394.01%
Free Cash Flow Per Share
-5.94-6.76-10.74
Levered Free Cash Flow
-691.33-535.41-840.41
Unlevered Free Cash Flow
-661.52-524.23-673.45